The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37037
StudyName: Eligibility Renal Cell Carcinoma NCT01984242
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 01.07.2019
License: Creative Commons BY 4.0

----

Description: 
A Phase 2 Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01984242
